Faust JS, Du C, Liang C, Mayes KD, Renton B, Panthagani K, et al. Excess mortality in Massachusetts during the delta and omicron waves of COVID-19. JAMA. 2022;328:74–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Golchin A, Seyedjafari E, Ardeshirylajimi A. Mesenchymal stem cell therapy for COVID-19: present or future. Stem Cell Rev Rep. 2020;16:427–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, et al. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 2016;24:490–502.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020;5:536–44.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:565–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chan JF, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020;395:514–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rabaan AA, Al-Ahmed SH, Haque S, Sah R, Tiwari R, Malik YS, et al. SARS-CoV-2, SARS-CoV, and MERS-COV: a comparative overview. Infez Med. 2020;28:174–84.

CAS  PubMed  Google Scholar 

Buchrieser J, Dufloo J, Hubert M, Monel B, Planas D, Rajah MM, et al. Syncytia formation by SARS-CoV-2-infected cells. EMBO J. 2020;39:e106267.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gerard L, Lecocq M, Bouzin C, Hoton D, Schmit G, Pereira JP, et al. Increased angiotensin-converting enzyme 2 and loss of alveolar type II Cells in COVID-19-related acute respiratory distress syndrome. Am J Respir Crit Care Med. 2021;204:1024–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020;14:185–92.

Article  PubMed  PubMed Central  Google Scholar 

Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang L, Han Y, Jaffré F, Nilsson-Payant BE, Bram Y, Wang P, et al. An immuno-cardiac model for macrophage-mediated inflammation in COVID-19 hearts. Circ Res. 2021;129:33–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nelemans T, Kikkert M. Viral innate immune evasion and the pathogenesis of emerging RNA virus infections. Viruses. 2019;11:961.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baruah V, Bose S. Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV. J Med Virol. 2020;92:495–500.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395:497–506.

Article  CAS  PubMed  Google Scholar 

Zhang W, Li L, Liu J, Chen L, Zhou F, Jin T, et al. The characteristics and predictive role of lymphocyte subsets in COVID-19 patients. Int J Infect Dis. 2020;99:92–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Henderson LA, Canna SW, Schulert GS, Volpi S, Lee PY, Kernan KF, et al. On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheumatol. 2020;72:1059–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han PL, Pang T, Diao KY, Yang ZG. Corona virus disease 2019 (COVID-19): the image tells the truth. Infection. 2020;48:981–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

To KK, Sridhar S, Chiu KH, Hung DL, Li X, Hung IF, et al. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic. Emerg Microbes Infect. 2021;10:507–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q, et al. Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis. 2020;11:216–28.

Article  PubMed  PubMed Central  Google Scholar 

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv. 2020. https://doi.org/10.1101/2020.01.31.929042.

Article  PubMed  PubMed Central  Google Scholar 

Chang D, Lin M, Wei L, Xie L, Zhu G, Dela Cruz CS, et al. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA. 2020;323:1092–3.

Article  PubMed  PubMed Central  Google Scholar 

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420–2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Q, Qin C, Liu M, Liu J. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis. Infect Dis Poverty. 2021;10:132.

Article  PubMed  PubMed Central  Google Scholar 

Choi JY, Smith DM. SARS-CoV-2 variants of concern. Yonsei Med J. 2021;62:961–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021;9:747–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Behnke J, Kremer S, Shahzad T, Chao CM, Böttcher-Friebertshäuser E, Morty RE, et al. MSC based therapies-new perspectives for the injured lung. J Clin Med. 2020;9:682.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cruz FF, Rocco P. The potential of mesenchymal stem cell therapy for chronic lung disease. Expert Rev Respir Med. 2020;14:31–9.

Article  CAS  PubMed  Google Scholar 

Abraham A, Krasnodembskaya A. Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome. Stem Cells Transl Med. 2020;9:28–38.

Article  CAS  PubMed  Google Scholar 

Liang P, Ye F, Hou CC, Pi L, Chen F. Mesenchymal stem cell therapy for patients with ischemic heart failure- past, present, and future. Curr Stem Cell Res Ther. 2021;16:608–21.

CAS  PubMed  Google Scholar 

Shafei AE, Ali MA, Ghanem HG, Shehata AI, Abdelgawad AA, Handal HR, et al. Mesenchymal stem cell therapy: a promising cell-based therapy for treatment of myocardial infarction. J Gene Med. 2017;19:e2995.